Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RBC Capital upgrades Rotork to 'outperform'

(Sharecast News) - RBC Capital Markets upgraded Rotork on Tuesday to 'outperform' from 'sector perform' as it pointed to the fact the valuation is at the low end of its 10-year range. The bank noted that Rotork shares have fallen in line with its sector over the last three months, but said it sees its business mix as more resilient, both in terms of end markets in general and specific tariff risks.

"Absolute EV/EBITA and price-to-earnings are both close to 25% discounts to their 10-year average and both absolute and relative valuations are at or below the low ends of their 10-year ranges," said RBC, which kept its price target at 370p.

It said that Rotork's direct tariff risk is limited, given a local-for-local business model for both assembly and its supply base.

"The company also has had a good track record of passing prices through to customers, including during the first Trump administration and post-Covid," it said.

At 1340 BST, the shares were up 1.9% at 298p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.